Clinical trial

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext

NCT01741194

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-03-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2013-03-01Date precision: month

Registry last updated2021-08-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Interventions

AC-1204DRUG

PlaceboDRUG

Sponsors & collaborators

Cerecinlead sponsor

Mapped research locations

Long BeachCalifornia, United States3 New YorkNew York, United States2 San DiegoCalifornia, United States2 TampaFlorida, United States2 PhoenixArizona, United States2 CharlotteNorth Carolina, United States2 BrooklynNew York, United States2 St. PetersburgFlorida, United States2 HoustonTexas, United States1 PhiladelphiaPennsylvania, United States1 DallasTexas, United States1 BaltimoreMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01741194 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.